Molecular cloning and expression of a receptor for human tumor necrosis factor

[1]  M. Meltzer,et al.  Tumor necrosis factor. , 1991, Journal of the American Academy of Dermatology.

[2]  D. Wallach,et al.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. , 1990, The Journal of biological chemistry.

[3]  H. Kung,et al.  Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells. , 1990, Journal of immunology.

[4]  J. Tomich,et al.  Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. , 1990, Lymphokine research.

[5]  S Vuk-Pavlović,et al.  Recycling of tumor necrosis factor‐a receptor in MCF‐7 cells , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  D. Gearing,et al.  Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor. , 1989, The EMBO journal.

[7]  Alan I. Alpert,et al.  The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.

[8]  D. Wallach,et al.  Soluble cytokine receptors are present in normal human urine , 1989, The Journal of experimental medicine.

[9]  H. Hohmann,et al.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). , 1989, The Journal of biological chemistry.

[10]  R. Smith,et al.  Multimeric structure of the tumor necrosis factor receptor of HeLa cells. , 1989, The Journal of biological chemistry.

[11]  J. Dayer,et al.  Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. , 1989, The Journal of biological chemistry.

[12]  D. Wallach,et al.  A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. , 1989, The Journal of biological chemistry.

[13]  R. Leimgruber,et al.  Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. , 1989, The Journal of biological chemistry.

[14]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[15]  I. Stamenkovic,et al.  A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. , 1989, The EMBO journal.

[16]  C. Nathan,et al.  Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. , 1989, The Journal of biological chemistry.

[17]  E. Nilsson,et al.  Isolation and characterization of a tumor necrosis factor binding protein from urine , 1989, European journal of haematology.

[18]  B. Aggarwal,et al.  Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line, U-937. , 1989, The Journal of biological chemistry.

[19]  M. Palladino,et al.  Tumor necrosis factor-alpha as a proliferative signal for an IL-2-dependent T cell line: strict species specificity of action. , 1989, Journal of immunology.

[20]  山崎 勝彦.  Cloning and expression of the human interleukin-6 (BSF-2/IFNβ2) receptor , 1989 .

[21]  B. Aggarwal,et al.  Human tumor necrosis factor-alpha receptor. Purification by immunoaffinity chromatography and initial characterization. , 1988, The Journal of biological chemistry.

[22]  I. Olsson,et al.  A tumor necrosis factor binding protein is present in human biological fluids , 1988, European journal of haematology.

[23]  B. Beutler,et al.  The history, properties, and biological effects of cachectin. , 1988, Biochemistry.

[24]  T. Taniguchi,et al.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.

[25]  C. March,et al.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. , 1988, Science.

[26]  H. Kuriyama,et al.  Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. , 1988, The Journal of biological chemistry.

[27]  D. Kufe,et al.  Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. , 1988, The Journal of biological chemistry.

[28]  D. Nelson,et al.  Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL). , 1988, Clinical and experimental immunology.

[29]  J. Dayer,et al.  A human inhibitor of tumor necrosis factor alpha , 1988, The Journal of experimental medicine.

[30]  D. Stites,et al.  In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. , 1988, Journal of immunology.

[31]  J. Vilček,et al.  Tumor necrosis factor-induced downregulation of its receptors in HeLa cells. , 1987, Journal of biochemistry.

[32]  D. Kufe,et al.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. , 1987, Journal of immunology.

[33]  R. Yamamoto,et al.  A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Shooter,et al.  Gene transfer and molecular cloning of the rat nerve growth factor receptor , 1987, Nature.

[35]  K. Kato,et al.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins , 1987, The Journal of experimental medicine.

[36]  M. Chao,et al.  Expression and structure of the human NGF receptor , 1986, Cell.

[37]  K L Gould,et al.  Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. , 1986, European journal of biochemistry.

[38]  S. Rogers,et al.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. , 1986, Science.

[39]  G. Heijne.  A new method for predicting signal sequence cleavage sites. , 1986 .

[40]  D. Goeddel,et al.  Tumor necrosis factors: gene structure and biological activities. , 1986, Cold Spring Harbor symposia on quantitative biology.

[41]  B. Aggarwal,et al.  Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon , 1985, Nature.

[42]  J. Tavernier,et al.  Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. , 1985, The Journal of biological chemistry.

[43]  D. Nelson,et al.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.

[44]  J. Vilček,et al.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Cuatrecasas,et al.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Lathe.  Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. , 1985, Journal of molecular biology.

[47]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[48]  P. Rigby,et al.  High efficiency gene transfer into mammalian cells. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[49]  D. Russell,et al.  The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA , 1984, Cell.

[50]  T. Honjo,et al.  Molecular cloning of cDNA encoding human interleukin-2 receptor , 1984, Nature.

[51]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[52]  Russell F. Doolittle,et al.  Computer-based characterization of epidermal growth factor precursor , 1984, Nature.

[53]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[54]  M. O. Dayhoff,et al.  Establishing homologies in protein sequences. , 1983, Methods in enzymology.

[55]  Jonathan A. Cooper,et al.  Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[57]  E. Krebs,et al.  Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase. , 1980, The Journal of biological chemistry.

[58]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[59]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[60]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[61]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. O. Dayhoff,et al.  Atlas of protein sequence and structure , 1965 .